Literature DB >> 11840230

Enhanced vasodilator responses to calcitonin gene-related peptide (CGRP) in subcutaneous arteries in human hypertension.

H Lind1, L Edvinsson.   

Abstract

Isolated segments (1-2 mm) of small subcutaneous arteries (diameter 0.1-0.9 mm) and veins (0.1-1.0 mm) from patients with hypertension (essential n = 13, renovascular n = 6) and controls (n = 17) were examined. The relaxant responses to the sensory transmitters calcitonin gene-related peptide (CGRP) and substance P, and the contractile responses to potassium and noradrenaline were studied. Enhanced dilatory responses (E(max)) but no change in sensitivity (pEC50) were demonstrated in the arteries but not in the veins to CGRP in hypertensives (P < 0.01) as compared with normotensives, and in the hypertensive subgroups (essential hypertension, P < 0.05; renovascular hypertension, P< 0.05). The relaxant responses to substance P were not altered either in arteries or in veins of hypertensives. Furthermore, there were no differences in the contractile responses to 60 mM potassium or to 10 microM noradrenaline between the groups. The results suggest that the enhanced vasodilator response to CGRP in hypertension is an adaptive reaction. The elevated blood pressure may be augmented by vasodilatory activity since different subgroups of hypertensives showed the same results. However, other common characteristics of hypertension (eg, medication, metabolic disturbances) may have also influenced the results.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11840230     DOI: 10.1038/sj.jhh.1001294

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  2 in total

Review 1.  Clinical data on the CGRP antagonist BIBN4096BS for treatment of migraine attacks.

Authors:  Lars Edvinsson
Journal:  CNS Drug Rev       Date:  2005

2.  Dynamics of calcitonin gene-related peptide-like cells changes in the lungs of two-kidney, one-clip rats.

Authors:  I Kasacka; E Arciszewska
Journal:  Eur J Histochem       Date:  2012-03-08       Impact factor: 3.188

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.